.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Colorcon
AstraZeneca
Mallinckrodt
Dow
Johnson and Johnson
Accenture
Cantor Fitzgerald
Healthtrust
McKinsey

Generated: November 21, 2017

DrugPatentWatch Database Preview

Claims for Patent: 6,133,418

« Back to Dashboard

Claims for Patent: 6,133,418

Title: Synthetic peptide inhibitors of HIV transmission
Abstract:The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP-178 (SEQ ID:1) ptide corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP-178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
Inventor(s): Bolognesi; Dani Paul (Durham, NC), Matthews; Thomas James (Durham, NC), Wild; Carl T. (Durham, NC)
Assignee: Duke University (Durham, NC)
Application Number:08/554,616
Patent Claims: 1. A peptide having the formula

in which amino acid residues are presented by the single-letter code wherein:

X is an amino group, an acetyl group, a 9-fluorenylmethoxy-carbonyl group, or a hydrophobic group; and

Z is a carboxyl group, an amido group, or a hydrophobic group.

2. A peptide having the formula

in which amino acid residues are presented by the single-letter code wherein:

X is an acetyl group; and

Z is an amido group.

3. A pharmaceutical composition comprising an effective amount of the peptide of claim 2 and a pharmaceutically acceptable carrier or excipient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
US Department of Justice
Mallinckrodt
Baxter
Daiichi Sankyo
McKesson
Healthtrust
Colorcon
Cantor Fitzgerald
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot